Week of March 12, 2024 | Vol. 13, Issue 11

Linkedin  

In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines



Quick Links

Who We Are

Investment Banking

Strategic Capital

Research


Contact Information

Xan Smith

Managing Director,

Business Development and Sponsor Coverage

xsmith@bourne-partners.com


Jeremy C. Johnson

Senior Managing Director, Head of Investment Banking

jjohnson@bourne-partners.com

Industry Snapshot

Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.

Upcoming Events

Events Hosted or Attended by Bourne Partners

dcat-week-2023 image
CHPA-logo-new image
ACGGlobal_wAssociationForCorporateGrowth_RGB_1 image
cphi-logo-rgb-na-colour image
MWlogo image
ACGNewYork image

DCAT Week 2024

March 18-21, 2024 - New York, NY

CHPA 2024

March 18-20, 2024 - Amelia Island, FL

ACG DealMAX 2024

April 29-May 1, 2024 - Las Vegas, NV

CHPI North America 2024

May 7-9, 2024 - Philadelphia, PA

McGuireWoods 20th Annual Healthcare Private Equity and Finance Conference

May 8-9, 2024 - Chicago, IL

2024 ACG New York 16th Annual Healthcare Conference

June 26, 2024 - New York, NY

Let's Meet!

Please reach out to Xan Smith to schedule a meeting with Bourne Partners in the following locations:

Industry M&A Activity

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

M&A Transactions

Pharma & Biotech

10 transactions totaling $530 million


Supplies, Equipment & Services

15 transactions totaling $712 million


Healthcare Facilities & Distributors

2 transactions


Healthcare IT & Managed Care

5 transactions totaling $130 million

Private Placements

Pharma & Biotech

30 transactions totaling $1,324 million


Supplies, Equipment & Services

24 transactions totaling $314 million


Healthcare Facilities & Distributors

4 transactions


Healthcare IT & Managed Care

12 transactions totaling $131 million

Public Offerings

Pharma & Biotech

29 transactions totaling $6,045 million


Supplies, Equipment & Services

6 transactions totaling $1,514 million


Healthcare Facilities & Distributors

2 transactions


Healthcare IT & Managed Care

5 transactions

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific subsectors.

Market Research

Insight Into Healthcare Related Industries

Bourne Brief: Navigating Tailwinds & Headwinds in Clinical Research Service

Bourne Partners - Nov 2023

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product


Project Ignatius

Pharma Services | Sell-Side

Acquisition opportunity of Phase I clinical research site



Project Nirvana

Pharma | Capital Raise

Investment opportunity in sterile injectable pharmaceutical manufacturer and compounder

Project Panther

Pharma Services | Capital Raise

Investment opportunity in OTC and personal care CDMO


Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

Lindus jumps on GLP-1 hype with 'all-in-one' CRO package for metabolic disease

Fierce Biotech

Genezen Announces Strategic Process Development and Manufacturing Partnership Agreement with Seattle Children's Research Institute for X-linked Agammaglobulinemia (XLA) Cell Therapy Program

PR Newswire

NovAliX and Max Planck Institute partner on cryo-EM-driven drug discovery

Fierce Biotech

CordenPharma Expands Early Clinical Peptide Manufacturing to Launch IND-Targeted Peptide API to Injectable Drug Product Integrated Offer

Corden Pharma

Adare Pharma Solutions To Expand Packaging & Warehousing Capabilities In Europe

Adare Pharma Solutions

Catalent Publishes Fifth Annual Corporate Responsibility Report, Highlighting Progress and Reinforcing Long-Term Commitment

Catalent

Perrigo's over-the-counter birth control launch takes flight in the US

Fierce Pharma

Argonaut Manufacturing Services Expands Aseptic Pharmaceutical Fill / Finish Capabilities with $45 Million Equity Investment from NewVale Capital and Telegraph Hill Partners

Business Wire